Scientific article

Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein

Published inBioconjugate chemistry, vol. 19, no. 2, p. 480-489
Publication date2008

New HIV prevention methods are needed, and among those currently being explored are "microbicides", substances applied topically to prevent HIV acquisition during sexual intercourse. The chemokine analogue PSC-RANTES (N(alpha)(n-nonanoyl)-des-Ser(1)-[ L-thioprolyl(2), L-cyclohexylglycyl(3)]-RANTES(4-68)) is a highly potent HIV entry inhibitor which has shown promising efficacy in its initial evaluation as a candidate microbicide. However, a way must be found to produce the molecule by cheaper means than total chemical synthesis. Since the only noncoded structures are located at the N-terminus, a possible solution would be to produce a protein fragment representing all but the N-terminal region using low-cost recombinant production methods and then to attach, site specifically, a short synthetic fragment containing the noncoded N-terminal structures. Here, we describe the evaluation of a range of different conjugation chemistries in order to identify those with potential for development as economical routes to production of a PSC-RANTES analogue with antiviral activity as close as possible to that of the parent protein. The strategies tested involved linkage through oxime, hydrazone/hydrazide, and Psi[CH2-NH] bonds, as well as through a peptide bond obtained either by a thiazolidine rearrangement or by direct alpha-amino acylation of a protein fragment in which 4 of the 5 lysine residues of the native sequence were replaced by arginine (the fifth lysine is essential for activity). Where conjugation involved replacement of one or more residues with a linker moiety, the point in the main chain at which the linker was introduced was varied. The resulting panel of 22 PSC-RANTES analogues was evaluated for anti-HIV activity in an entry inhibition assay. The [Arg (25,45,56,57)] PSC-RANTES analogue has comparable potency to PSC-RANTES, and one of the oxime linked analogues, 4L-57, has potency only 5-fold lower, with scope for improvement. Both represent promising leads for development as microbicide compounds that could be produced at low cost via semisynthesis.

  • Chemokine CCL5/chemistry/pharmacology
  • Chromatography High Pressure Liquid
  • HIV Fusion Inhibitors/pharmacology
  • Hela Cells
  • Humans
  • Spectrometry Mass Electrospray Ionization
Research group
Citation (ISO format)
GAERTNER, Hubert François et al. Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein. In: Bioconjugate chemistry, 2008, vol. 19, n° 2, p. 480–489. doi: 10.1021/bc7003044
Main files (1)
Article (Accepted version)
ISSN of the journal1043-1802

Technical informations

Creation02/04/2009 10:30:00 AM
First validation02/04/2009 10:30:00 AM
Update time03/14/2023 2:59:43 PM
Status update03/14/2023 2:59:43 PM
Last indexation01/18/2024 7:27:17 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack